Abstract
A clinical decision report using:
Neeland IJ, Eliasson B, Kasai T, et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care. 2020;43(12):3007-3015. https://doi.org/10.2337/dc20-1096
for a patient with obstructive sleep apnea who has not seen a physician in over 40 years.
DOI
10.22237/crp/1724284980
Creative Commons License
This work is licensed under a Attribution 4.0 International (CC-BY 4.0) License
Recommended Citation
DEMKO A. Use of empagliflozin as an adjuvant treatment for obstructive sleep apnea for a patient who has not seen a physician in over 40 years. Clin Res Prac. Nov 27 2024;10(1):eP3293. https://doi.org/10.22237/crp/1724284980
Included in
Cardiovascular Diseases Commons, Medical Education Commons, Respiratory Tract Diseases Commons, Translational Medical Research Commons
